The NMJI
VOLUME 18, NUMBER 2

MARCH / APRIL 2005


ORIGINAL ARTICLES

Cardiovascular risk factor prevalence among men in a large industry of northern India
D. Prabhakaran, Pankaj Shah, Vivek Chaturvedi, Lakshmy Ramakrishnan, Ajay Manhapra, K. Srinath Reddy

ABSTRACT
    Background.Industrial settings, with their intramural resources and healthcare infrastructure, are ideal for initiating preventive activities to increase the awareness and control of cardiovascular diseases (CVD). However, there are no reliable estimates of CVD and risk factor burden, nor of its awareness and treatment status in urban Indian industrial settings. We aimed to evaluate the prevalence of CVD and its risk factors, and to assess the status of awareness and control of CVD risk factors among a large industrial population of northern India.
    Methods.We conducted a cross-sectional survey among all employees aged 20–59 years of a large industry near Delhi (n=2935), to evaluate their cardiovascular risk profile—by employing a structured questionnaire and clinical and biochemical estimations. The presence of coronary heart disease was ascertained by evidence of its treatment, Rose angina questionnaire and Minnesota coded electrocardiograms.
    Results.The results for 2122 men, in whom complete information was available, are reported here. The mean age was 42 years and 90% of the men were below 50 years of age. The prevalence of major CVD risk factors (95% CI) was: hypertension 30% (28%–32%), diabetes 15% (14%–17%), high serum total cholesterol/HDL ratio (>4.5) 62% (60%–64%) and current smoking 36% (34%–38%). Forty-seven per cent of the respondents had at least two of these risk factors. Another 44% (95% CI: 42%–46%) had pre-hypertension (JNC VII criteria) and 37% (95% CI: 35%–39%) had evidence of either impaired fasting glucose or impaired glucose tolerance. Thirty-five per cent (95% CI: 33%–37%) of the individuals were overweight (BMI >25 kg/m2) while 43% (95% CI: 40%–45%) had central obesity (waist circumference >90 cm). The metabolic syndrome was present in 28%–35% of the individuals depending on the diagnostic criteria used. The prevalence of several risk factors and the metabolic syndrome was high with increasing age, BMI and waist circumference. A third of those who had hypertension (31.5%) and diabetes (31%) were aware of their status. Among those aware, adequate control of blood pressure and blood glucose was present in only 38% of those with hypertension and 31% of those with diabetes, respectively. Coronary heart disease was present in 7.3% of the individuals while 0.3% had a history of stroke.
    Conclusion.This study demonstrates the high prevalence of CVD and its risk factors against a background of poor awareness and control among a comparatively young male population in a north Indian industrial setting.
Natl Med J India 2005;18:59–65

INTRODUCTION
The cardiovascular disease (CVD) burden of India is expected to double in the next two decades, making it the single largest cause of death and the second largest cause of disability by the year 2020.1 This will be characterized by an enormous burden of CVD among urban communities. Further, the prevalence of CVD in rural and semi-urban areas is expected to increase substantially.2,3 While the exact aetiology of this predisposition to CVD in Indians is still debated, from a public health point of view it is clear that the rapid transition in diet and lifestyles with urbanization has contributed to increasing levels of potentially reversible CVD risk factors.
4 Data from several cross-sectional studies confirm the high prevalence of risk factors such as smoking, type 2 diabetes, high blood pressure, dyslipidaemia and obesity511 in urban Indians. Despite this high burden, there is poor awareness among Indians, in addition to low detection and control rates.1218 The reasons for this include low literacy, lack of access to healthcare and competing priorities such as infectious and nutritional diseases. Given this background and with the expected overall improvement in literacy and socioeconomic status, it would be useful to study the awareness of CVD risk factors and lifestyle patterns in industrial settings, where the access to healthcare is usually better than that among the general community.
    Recent research has highlighted the importance of a continuum of risk with variables such as blood pressure and glucose.
1923 There is robust evidence of increased vascular risk even in the presence of pre-hypertension (or high-normal blood pressure) and pre-diabetes (impaired fasting glucose and impaired glucose tolerance).24,25 These risk categories have a high rate of progression to hypertension and type 2 diabetes. They are also components of the metabolic syndrome, which confers an almost 2-fold risk for future diabetes, CVD mortality and morbidity.26,27 However, detailed data regarding the burden of these risk factors in India are limited.
    We report the findings of a survey done among the employees of a large organized sector industry located close to Delhi. The main objectives of the study were (i) to study the risk factor and treatment status in individuals with respect to CVD, (ii) to estimate the prevalence of risk factors for coronary heart disease (CHD), both traditional and intermediary, and (iii) to estimate the prevalence of CHD using a history of previously diagnosed disease, Rose angina questionnaire and electrocardiogram (ECG).

METHODS
Study design and setting
We did a cross-sectional survey of all employees in the 20–59 years’ age group in an organized sector industry, during 1995–98. A total of 2935 employees (344 women and 2591 men) were eligible to participate. All potential participants received a letter inviting them to participate in the study. Approval for conducting the study was obtained both from the management and the employee representatives. Participation in the study was voluntary and all the measurements were carried out in the medical unit located within the industry. Informed consent was obtained from each participant.

Study questionnaire
We used a simple structured questionnaire which was administered by research assistants, who had received training in the methodology of field-based cardiovascular surveys. The questionnaire was used to elicit information from each study participant for the following variables: (i) demographic characteristics such as age, marital status, profession, education and socioeconomic status; (ii) lifestyle-related factors such as dietary habits, physical activity, tobacco and alcohol consumption; (iii) the health status of the individual and any history related to heart disease, stroke, hypertension and diabetes. The presence of angina was assessed using the Rose angina questionnaire. If a person reported the presence of hypertension or diabetes or CVD (defined as the presence of CHD or stroke or angina), a detailed questionnaire was administered to elicit information on control, awareness, treatment and limitations due to the illness. Each question was structured to gather as much information as possible without increasing the duration of the interview, which usually lasted about 30 minutes.

Clinical measurements and anthropometry
A 30 second pulse rate was measured in each individual followed by 2 blood pressure measurements using a random zero sphygmomanometer by standard techniques.
28 The measurements were obtained half an hour apart, either before or 1 hour after the first blood sampling. The lower of the two measurements was used for this analysis. Height was measured in centimetres using a stadiometer, which was calibrated to the nearest 0.5 cm, and weight was measured using a bathroom scale, which was validated on a daily basis with known weights.
    Waist and hip circumferences were measured in the following manner. The subject was asked to stand with the arms by the sides and to breathe normally. The following points were marked on the right side: (i) the subcostal margin in the mid-axillary line, (ii) the highest point of the iliac crest in the mid-axillary line. The centre of these two points was marked. At this point the waist circumference was measured with a fibreglass tape after applying a tension of 600 g (done with the help of a spring balance). The measurement was made up to the nearest millimetre. Adequate care was taken to ensure that the subject was breathing normally at the time the measurement was taken. Hip circumference was measured at the level of the greater trochanters with the subject standing and breathing normally in a manner similar to that during measurement of the waist circumference. All the measurements were taken without intervening clothes, with the subject wearing a loose-fitting surgical gown.
    An ECG was obtained after the clinical measurements. All ECGs were read by a cardiologist and coded using the Minnesota coding system. Ten per cent of randomly selected ECGs were checked by two different cardiologists for agreement. There was complete agreement between the original and fresh coding. (Kappa was not estimated in view of the complete agreement.)

Laboratory measurements
Blood samples were drawn by trained personnel, centrifuged and stored for later analysis. Laboratory measurements included estimation of fasting blood glucose, 2-hour post-load blood glucose (all post-load measurements were made 2 hours after a 75 g glucose solution was administered orally under supervision), plasma insulin (both fasting and post-load), total blood cholesterol, high density lipoprotein (HDL) cholesterol (HDL-C), and triglycerides (both fasting and post-load). Glucose was analysed by the glucose oxidase method (GOD-PAP), cholesterol by the CHOD-PAP method, and triglycerides were estimated by the GPOD-PAP method. The intra- and interassay coefficient of variation (CV) for glucose was 1.5% and 2%, respectively; for cholesterol and triglycerides these were <2% and <2.5%, respectively. HDL-C was estimated by the precipitation method (phosphotungstate/Mg) and the inter- and intra-assay CVs were <2.5%. Insulin concentrations were measured by radioimmunoassay (Coat-a-Count insulin kit, Diagnostic Products). The intra- and interassay CVs were <5% and <7.5%, respectively.

Definition of risk factors
The definitions used for the categorization of risk levels among the participants are given in Box 1.

Statistical analysis
Statistical analysis was performed using the SPSS Version 9.0 package. Continuous data are summarized as means and standard deviations and categorical data as proportions. We used the Student t test for comparing means and a chi-square test for categorical variables.

RESULTS
Of the 2935 eligible individuals (11.7% women), 2548 (86.8% of total, 266 women and 2282 men) agreed to participate in the study. We report here the results of the men, as the number of women who were eligible and participated in the study was small (10.4%). Of the 2282 men, 14 declined to undergo clinical examination or give blood samples. Complete data for all the risk variables were available for 2122 subjects.

Demographic characteristics
The mean age of the participants was 42 years. Nearly 60% of the participants were in the 41–50 years’ age group (Table I). A large

Box 1. Definitions for different risk factors in the study

Hypertension: Systolic blood pressure (BP) >139 mmHg or diastolic BP >89 mmHg or history of treatment for hypertension
Pre-hypertension: Systolic BP of 120–139 mmHg or diastolic BP of 80–89 mmHg in non-hypertensive subjects
Diabetes: Fasting blood glucose >126 mg/dl or 2-hour post-load blood glucose >200 mg/dl or history of treatment for diabetes
Impaired fasting glucose: Fasting blood glucose >100 mg/dl and <126 mg/dl, in the non-diabetic population
Impaired glucose tolerance: Fasting glucose <126 mg/dl and 2-hour post-load blood glucose of 140–199 mg/dl in the non-diabetic population
Tobacco use: Consumption of any form of tobacco in the past 6 months. The types of tobacco consumption considered included smoked (cigarettes, beedis and cigars), oral (tobacco chewed, pan masala, etc.) and inhaled forms (snuff)
Hypercholesterolaemia: Total blood cholesterol levels >200 mg/dl
Hypertriglyceridaemia: Fasting serum triglyceride levels >150 mg/dl
Decreased high density lipoprotein cholesterol: Fasting blood HDL-cholesterol <40 mg/dl
Adverse total cholesterol/high density lipoprotein cholesterol ratio: ³4.5
Overweight: Body mass index* ³25 kg/m2
Central obesity: Among men a waist circumference of >94 cm (as per the NCEP-ATP III guidelines for genetically high risk men) or a waist–hip ratio >0.90 as per the WHO criteria indicated central obesity
Coronary heart disease (CHD): A positive history of CHD or presence of ECG abnormalities 1-1-1, 1-1-2, 1-1-3, 1-1-4, 1-1-5, 1-1-6 and 1-1-7 representing major Q waves; 4-1-1 and 4-1-2 representing ST–T changes and 5-1 and 5-2 representing T wave changes in the Minnesota coding system
Metabolic syndrome:
NCEP-ATP III criteria:32 For men, presence of >3 of the following: fasting plasma glucose levels >110 mg/dl, serum triglycerides >150 mg/dl, serum high density lipoprotein cholesterol <40 mg/dl, blood pressure >130/85 mmHg, and waist girth >102 cm. Use of waist circumference >94 cm suggested for men who might be genetically susceptible to insulin resistance
WHO criteria:33 For men, insulin resistance in the top 25% of the population as measured by the euglycaemic–hyperinsulinaemic clamp method or the presence of impaired glucose tolerance or type 2 diabetes, and the presence of at least 2 of the following: abdominal obesity (waist–hip ratio >0.90 or body mass index >30 kg/m2), dyslipidaemia (serum triglycerides >150 mg/dl) or high density lipoprotein cholesterol <35 mg/dl, hypertension (>160/90 mmHg), or microalbuminuria
*BMI is obtained by dividing the weight in kilograms by the square of the height in metres. Recent data suggest that this cut-off possibly underestimates obesity in Asians and hence we also report overweight using the cut-off of BMI ³23 kg/m2
NCEP-ATP III National Cholesterol Education Program Adult Treatment Panel III

majority were educated with 66.4% having graduate, postgraduate or professional qualifications. Twenty-one per cent had secondary level education and the remaining 12.6% were illiterate (Table I). The majority of employees were either skilled workers (47%) or professionals (26%). Semi-skilled and unskilled workers constituted 14% and 2.4% of the workforce, respectively. The remaining were clerical staff (11.5%).

Table I. Baseline characteristics of the study population (n=2122)
Characteristic Percentage
Age group (years)
21–30
5.5
31–40
25.4
41–50
59.2
51–59
9.8
Educational achievements
No education or some education*
12.6
Secondary school
21
Graduate/postgraduate/professional
66.4
 
Clinical, laboratory, and anthropometric measurements
Mean (SD)
Mean age (years)
42 (6.5)
Systolic blood pressure (mmHg)
122 (13.3)
Diastolic blood pressure (mmHg)
83 (9.5)
Fasting blood glucose (mg/dl)
101 (32.6)
Fasting serum insulin (IU/L)†
9.4 (16.7)
log insulin†
1.7 (0.8)
Total blood cholesterol (mg/dl)
180.5 (45.5)
Low density lipoprotein cholesterol (mg/dl)
114.4 (43.5)
High density lipoprotein cholesterol (mg/dl)
36.4 (9.7)
Serum fasting triglycerides (mg/dl)
149 (95)
Total/high density lipoprotein cholesterol ratio
5.3 (1.9)
Body mass index (kg/m2)
23.7 (3.4)
Waist circumference (cm)
87.6 (10.3)
Waist–hip ratio
0.97 (0.06)
*primary education †30 missing values, n=1812

Risk factors
The mean values of various clinical, laboratory and anthropometric measurements are given in Table I. The age-stratified and total prevalence of CVD risk factors are given in Table II. Normal blood pressure (systolic pressure <120 mmHg and diastolic pressure <80 mmHg, respectively) was observed in a quarter (25.6%) of the individuals surveyed. The prevalence of pre-hypertension and hypertension as per the Seventh Joint National Committee (JNC VII) criteria was 44% (95% CI: 42%–47%) and 30% (95% CI: 28%–32%), respectively. Among those with hypertension only one-third (31.5%) were aware of their blood pressure status. Of these, only 38% (12% of the total who were hypertensive) had their blood pressure under control (<140/90 mmHg). The proportion of individuals with hypertension who were aware of their disease increased with age (from 19% of all those with hypertension in the 20–29 years’ age group to 40.5% in the 50–59 years’ age group). Diabetes was present in 15% (95% CI: 14%–17%) and another 30.7% (95% CI: 29%–33%) had evidence of abnormal glucose homeostasis, denoted by impaired fasting glucose. Impaired glucose tolerance, an indicator of insulin resistance, was observed in 13.2% (95% CI: 12%–15%) of participating individuals (Table II). While 31% of those with diabetes were aware of their status, in only 17% of these (5% of the people with diabetes) was the blood glucose controlled to normoglycaemic levels (fasting plasma glucose <100 mg/dl and postprandial glucose <140 mg/dl)). The proportion of individuals with diabetes who were aware of their disease increased with age (from 20% of all those with diabetes in the 20–29 years’ age group to 42.1% in the 50–59 years’ age group).

Table II. Overall and age-stratified prevalence (%) of risk factors
Risk factor
Total (95% CI)
Age group (in years)
21–30 31–40 41–50 51–59
Hypertension
30 (28–32)
18.1
21
33.2
40.2
Pre-hypertension
44 (42–46)
55.2
55.1
41.7
40.2
Normal blood pressure
25.6
26.7
28.9
25.1
19.6
Diabetes
15 (14–17)
4.3
10.4
17.6
18.3
Normal glucose tolerance (fasting glucose <100 mg/dl)
48.1
52.2
50.2
47.0
46.6
Isolated impaired fasting glucose* (IFG)
23.6
34.8
25.0
22.1
22.6
Isolated impaired glucose tolerance† (IGT)
6.1
3.5
8.3
5.6
4.8
IFG and IGT combined
7.2
5.2
6.1
7.7
7.7
IFG or IGT
37 (35–39)
43.5
39.4
35.4
35.1
Total cholesterol
>200 mg/dl
30.1 (28–32
21.6
29.6
30.9
31.1
>240 mg/dl
9.8 (8.5–11)
6
9.6
10.3
9.6
Low density lipoprotein cholesterol

>130 mg/dl
33 (31–35)
26
33
34
31.6
>160 mg/dl
13.6 (12–15)
9.5
14
14
13.4
High density lipoprotein cholesterol
67.2 (65–69)
66.4
69.1
67.1
63.2
Total/high density lipoprotein cholesterol ratio ³4.5
62 (60–64)
53.4
60
64.1
56.5
Fasting triglycerides
>150 mg/dl
38 (38–42)
19.8
36.1
38.9
46.4
>200 mg/dl
19.9 (18–22)
12.1
17.4
21.4
21.5
Tobacco use
48.3
Current tobacco smoking
36 (34–38)
15.5
35.6
37.0
41.1
Overweight (BMI ³25 kg/m2)
35 (33–37)
18.1
29.1
37.2
44.5
Obese (BMI ³30 kg/m2)
3.3 (2.6–4.1)
0
24
4.0
3.8
BMI ³23 kg/m2
58.5 (56.4–60.6)
0
Central obesity (waist circumference >102 cm)
7.2 (6.0–8.3)
0
4.6
7.9
13.4
Waist circumference
>94 cm
26.5 (25–28)
5.2
18.1
29.9
39.7
>90 cm
43 (40–45)
10.3
32.2
47.7
56.5
Waist–hip ratio
³0.95
66.6 (64.6–68.6)
28.4
54.6
73.4
77.5
³0.90
88.7 (87.3–90.0)
66.4
84.1
92.0
93.3
Presence of ³2 major risk factors‡
47
23.5
39
51.3
51.4
CI confidence interval BMI body mass index * after excluding IGT from the analysis † after excluding IFG from the analysis
‡ hypertension, diabetes, current smoking, and total/high density lipoprotein cholesterol ratio ³4.5


Hypercholesterolaemia (total cholesterol ³200 mg/dl) was observed in 30.1% (95% CI: 28%–32%) of individuals, and hypertriglyceridaemia (serum fasting triglycerides ³150 mg/dl) in 38% (95% CI: 38%–42%) of those surveyed (Table II). A large proportion (67.2% [95% CI: 65%–69%]) of individuals had low HDL-C levels (serum HDL-C <40 mg/dl), which resulted in nearly two-thirds (62%) of individuals having a total cholesterol/HDL-C ratio of ³4.5. Overall, this population had a high rate of tobacco use (48.3%); 36% of the individuals were current smokers (cigarettes 21.5% and beedis 19.7%), and one-quarter of the population used non-smoking forms (Table II). The commonest non-smoking form of tobacco use was chewing tobacco or pan masala mixed with tobacco.
One-third of the population (35% [95% CI: 33%–37%]) was overweight using the traditional cut-off of BMI ³25 kg/m2. However, as per the recent WHO recommendations for defining health risks associated with BMI in Asians, 12.2% were in the ‘high to very high’ risk (BMI ³27.5 kg/m2) category and 58.5% in the ‘moderate to high risk’ (BMI ³23 kg/m2) category
29 (Table II). Similarly, very few individuals were centrally obese by the National Cholesterol Education Program (NCEP) criteria of waist circumference >102 cm (7.2%). However, 43% (95% CI: 40%–45%) of the individuals had a waist circumference ³90 cm, the proposed criteria for central obesity in men in the Asia-Pacific region,30 while 26.5% (95% CI: 25%–28%) had a waist circumference >94 cm, the proposed first action level in the Caucasian population.31

Table III. Prevalence (%) of the metabolic syndrome (n=2120)
Criteria for metabolic syndrome
Total
Age group (in years)
21–30 31–40 41–50 51–59
NCEP criteria
28.1
12.9
23.4
29.8
38.3
NCEP modified criteria*
35.3
14.7
29
37.9
47.8
Modified WHO criteria†
29
16.4
25.8
30.6
34.6
NCEP National Cholesterol Education Programme
* Waist circumference >94 cm (in genetically susceptible populations); other criteria are the same
† Revised definition of WHO metabolic syndrome: microalbuminuria not included as a criterion; blood pressure (BP) thresholds for defining hypertension taken as systolic BP ³140 mmHg and diastolic BP ³90 mmHg; dysglycaemia defined as presence of diabetes or impaired fasting glucose or impaired glucose tolerance (insulin parameters not used)

The metabolic syndrome was present in 28.1% (95% CI: 26%–30%) of the study population (Table III) by the NCEP Adult Treatment Panel (ATP) III criteria (see Box 1).32 Using the criteria for genetically susceptible populations (waist circumference >94 cm instead of 102 cm), the prevalence of the metabolic syndrome was higher (35%). Using the modified WHO criteria33 for defining the metabolic syndrome (see Box 1 and Table III), the prevalence was 29% (95% CI: 27%–31%). The prevalence of the metabolic syndrome using the modified NCEP definition was 29% after individuals with diabetes were excluded, and 21.7% when only individuals with normoglycaemia were considered. Among 1798 individuals without diabetes, fasting serum insulin levels were available for 1552 persons. The mean and median values of insulin were 8.8 IU/L and 5.0 IU/L, respectively. After log transformation of insulin values to make the distribution normal, the mean values of insulin were consistently higher in those with the metabolic syndrome as compared to those without (1.9 and 1.67, respectively, among those with and without the metabolic syndrome, p for difference <0.001) irrespective of the way the metabolic syndrome was defined.
Only 15% of the study population were free from any of the risk factors (hypertension, diabetes, current smoking and total cholesterol/HDL-C ratio ³4.5). While 85% of the study population had at least 1 of these risk factors, about 47% of the employees had at least 2 co-existing risk factors.
Effect of age on CVD risk factors
While diabetes, hypertension, hypertriglyceridaemia, overweight, central obesity and the metabolic syndrome, as well as the presence of multiple risk factors showed rising trends with age, the prevalence of smoking, low HDL and adverse total cholesterol/HDL-C ratio was roughly similar in all the age groups (Table II). Even the youngest age group of 20–29 years had a high prevalence of risk factors such as dyslipidaemia, hypertension and diabetes.
Effect of adiposity on CVD risk factors
There was a continuous graded increase in mean values as well as risk factor prevalence with increasing BMI (Fig. 1) and waist circumference (Fig. 2). The risk of developing obesity-associated risk factors started to rise much below the defined thresholds for western populations (BMI >25 kg/m2 and waist circumference >94 cm).
Prevalence of CVD

Fig 1. Prevalence of risk factors in the four quartiles of body mass index (all values in kg/m2)
Quartile I: 13.9–21.2; Quartile II: 21.3–23.7; Quartile III: 23.8–25.8; Quartile IV: 25.9–37.2
*TC:HDL ratio total cholesterol:high density lipoprotein cholesterol ratio
† Metabolic syndrome as defined by the NCEP-ATP III but excluding waist circumference from the definition
Fig 2. Prevalence of risk factors in the four quartiles of waist circumference (all values in cm)
Quartile I: 51.4–81.0; Quartile II: 81.1–88.0; Quartile III: 88.1–94.5; Quartile IV: 94.6–131
*TC:HDL ratio total cholesterol:high density lipoprotein cholesterol ratio
† Metabolic syndrome as defined by the NCEP-ATP III but excluding waist circumference from the definition

A past history of diagnosed CHD and stroke was identified in 16 (0.8%) and 7 (0.3%) individuals, respectively. The prevalence of CHD, defined as history of CHD (identified by the modified Rose questionnaire) or presence of ECG abnormalities suggestive of CHD (by specified Minnesota codes), was noted in 7.3% of men. Abnormal ECGs suggestive of CHD in the form of Q waves, T wave and ST–T abnormalities were observed in 2.5% of the population studied.
DISCUSSION
Our study on the cardiovascular risk profile in a industrial workplace setting in India, among a relatively young urban population, found the prevalence of traditional risk factors to be high. Even in the 20–29 years’ age group, only one-quarter of the individuals had normal blood pressure, only half had normal glucose tolerance, more than half had dyslipidaemia, one-fifth were overweight, and more than one-fifth had at least 2 major risk factors. Awareness and control of hypertension and diabetes was poor, indicating low detection and poor management of major CVD risk factors. The high prevalence of ‘risk markers’ such as impaired fasting glucose and glucose tolerance, and pre-hypertension suggests that there is a large vulnerable population which can develop an overt adverse risk profile and CVD in the future.
Community-based cross-sectional surveys and other studies carried out in the past few decades have revealed a high and increasing prevalence of CVD and its risk factors in individuals of South Asian origin residing, in India as well as in other countries.
511,3437 However, not many of these have evaluated the CVD risk profile in younger populations. The disconcertingly low level of awareness of CVD and its treatment further increases the risk for future morbidity and mortality due to CVD. The low awareness and control noted in our population is similar to data published from other developing countries such as China. Tao et al.38 from their nationwide survey of blood pressure of more than 950 000 men and women, found that of all the hypertensives, only 25% were aware of their hypertensive status and, among those aware, only half were on any blood pressure lowering medications. Overall, in only 3% was the blood pressure controlled to normal levels, although this had improved by 2000–01.39 Further, a recent report highlights the urban–rural differences in the awareness, treatment and control of hypertension. The Hypertension Study Group40 while noting similar low rates of awareness and control, identified visit to a physician in the previous 1 year, higher educational attainment and female gender to be important correlates of awareness among a cross-section of subjects with hypertension from India and Bangladesh. Therefore, while opportunistic screening may identify individuals with undetected hypertension and diabetes, we need specific strategies to improve the control and therapy of those with CVD risk factors.
The importance of insulin resistance in determining the high mortality due to CVD among Indians has been highlighted by McKeigue41 and Hughes.
42 Based largely on data obtained from migrant Indians and comparing them to indigenous populations, Indians were believed to have an enhanced propensity to insulin resistance and CVD.41 Though others have questioned the role of insulin resistance and emphasized the importance of conventional risk factors such as lipids, the high prevalence of the metabolic syndrome and its association with hyperinsulinaemia indirectly underscores the importance of insulin resistance among Indians. We explored the causes for the high prevalence of the metabolic syndrome in our study population and found overweight and central obesity to be major correlates of these risk markers (Figs. 1 and 2). As there is a pronounced urban–rural gradient in obesity among Asian Indians,43 we believe that the high prevalence of risk markers such as impaired glucose tolerance, the metabolic syndrome and high-normal blood pressure, all of which are influenced by body fat, is a reflection of the current urbanization and adaptation of a western lifestyle among the Indian population. The prevention and management of the metabolic syndrome largely involves lifestyle modifications. Recently published clinical trials such as the Diabetes Prevention Programme44 and the Finnish diabetes prevention studies45 have established the importance of lifestyle measures in the prevention of diabetes. Similarly, a low level of physical activity and a diet rich in saturated fats and high glycaemic foods have been implicated in the pathogenesis of the metabolic syndrome.46
While such a high prevalence of risk factors is a cause for concern, organized sector industries provide a unique opportunity for carrying out prevention programmes. It is estimated that there are nearly 6 million people working in such large organized sector industries in India. While most of these have their own primary healthcare facilities, they also provide for the healthcare of employees and their dependents in higher medical institutions when required. With the rising burden of CVD, the expenditure on such healthcare programmes by every industry is likely to increase enormously. Thus, there is a lot of scope for and benefit in initiating comprehensive, low-cost CVD prevention programmes at the workplace for employees and their dependants. Such onsite programmes have been found to be modestly successful in the West through increased awareness, health education and risk reduction interventions, and modified models could easily be adapted to Indian settings. This is likely to lead to a healthier workforce as well as a decrease in expenditure by the industry on treatment costs and increased absenteeism. We hope that our study will provide the stimulus for initiating such surveillance and preventive activities.
The prevalence rates that we have reported are based on western cut-offs and we require a longitudinal evaluation of our study population on CVD morbidity and mortality to fully understand the implications of our findings. To address the above issues, and to document changes in risk factors and prospectively identify determinants of CVD, we are continuing our study in this industrial population.
Limitations
As the study was carried out in an industrial setting, it may not be representative of the general population. Though we have provided age-specific prevalence rates, the industrial population is different from the general population in terms of its socioeconomic profile. However, this study is broadly generalizable to similar large, organized sector workforce involving nearly 6 million employees. Further, our study population comprised predominantly young men. Also, women comprised only 10% of the workforce. The results of this study cannot be generalized to individuals older than 60 years, in whom the risk factor as well as disease burden will be even higher than that reported in this population.
Conclusion
We have demonstrated a high prevalence of CVD risk factors, its markers such as the metabolic syndrome and risk determinants such as obesity (both generalized and central) among a group of young men. Though the study population was not representative of the national population (older, only men, higher educational and socioeconomic strata), we believe that it does represent the rising trend of CVD in urban India. Despite the availability of onsite healthcare and a high level of education as compared to the general population, the awareness and treatment of hypertension and diabetes is low. Therefore, there is a pressing need to initiate onsite preventive programmes to identify and manage individuals at high risk for future CVD.
ACKNOWLEDGEMENTS
The International Clinical Epidemiology Network (INCLEN) provided partial financial support for this study.
We gratefully acknowledge the cooperation of the employees and the management of Bharat Electronics Limited for participating in this study, Dr S. K. Puri and Dr Medha Joshi for providing clinical support at the industrial site, A. Karthika for data management, and all the research and support staff, without whom this study would not have been possible.

REFERENCES

  1. Murray CJL, Lopez AD. Global health statistics: Global burden of disease and injury series. Vols. I and II. Boston:Harvard School of Public Health; 1992.
  2. Gupta R, Gupta VP. Meta-analysis of coronary heart disease prevalence in India. Indian Heart J 1996;48:241–5.
  3. Krishnaswami S, Joseph G, Richard J. Demands on tertiary care for cardiovascular diseases in India: Analysis of data for 1960–89. Bull World Health Organ 1991;69: 325–30.
  4. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998;97:596–601.
  5. Chadha SL, Gopinath N, Shekhawat S. Urban–rural differences in the prevalence of coronary heart disease and its risk factors in Delhi. Bull World Health Organ 1997;75:31–8.
  6. Gupta R, Gupta VP, Sarna M, Bhatnagar S, Thanvi J, Sharma V, et al. Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur Heart Watch-2. Indian Heart J 2002;54:59–66.
  7. Ramachandran A, Snehalatha C, Latha E, Satyavani K, Vijay V. Clustering of cardiovascular risk factors in urban Asian Indians. Diabetes Care 1998;21:967–71.
  8. Joseph A, Kutty VR, Soman CR. High risk for coronary heart disease in Thiruvananthapuram city: A study of serum lipids and other risk factors. Indian Heart J 2000;52:29–35.
  9. Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, Khanna N. High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes Relat Metab Disord 2001;25:1722–9.
  10. Pais P, Pogue J, Gerstein H, Zachariah E, Savitha D, Jayprakash S, et al. Risk factors for acute myocardial infarction in Indians: A case–control study. Lancet 1996;348:358–63.
  11. Mohan V, Deepa R, Rani SS, Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: The Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol 2001;38:682–7.
  12. Deepa R, Shanthirani CS, Pradeepa R, Mohan V. Is the ‘rule of halves’ in hypertension still valid?—Evidence from the Chennai Urban Population Study. J Assoc Physicians India 2003;51:153–7.
  13. Zachariah MG, Thankappan KR, Alex SC, Sarma PS, Vasan RS. Prevalence, correlates, awareness, treatment, and control of hypertension in a middle-aged urban population in Kerala. Indian Heart J 2003;55:245–51.
  14. Gupta AK, Ahluwalia SK, Negi PC, Sood RK, Gupta BP, Dhadwal D. Awareness of hypertension among a north Indian population. J Indian Med Assoc 1998;96: 298–9, 311.
  15. Chadha SL, Radhakrishnan S, Ramachandran K, Kaul U, Gopinath N. Prevalence, awareness and treatment status of hypertension in urban population of Delhi. Indian J Med Res 1990;92:233–40.
  16. Qiao Q, Hu G, Tuomilehto J, Nakagami T, Balkau B, Borch-Johnsen K, et al. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 2003;26:1770–80.
  17. Mohan V, Shanthirani CS, Deepa R. Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and lifestyle factors—The Chennai Urban Population Study (CUPS 14). J Assoc Physicians India 2003;51:771–7.
  18. Zargar AH, Khan AK, Masoodi SR, Laway BA, Wani AI, Bashir MI, et al. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in the Kashmir valley of the Indian subcontinent. Diabetes Res Clin Pract 2000;47:135–46.
  19. Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ 1991;303:276–82.
  20. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994;308:367–72.
  21. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360: 1903–13.
  22. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765–74.
  23. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000;321:405–12.
  24. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet 1980;1:1373–6.
  25. Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345:1291–7.
  26. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709–16.
  27. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: The San Antonio heart study. Diabetes Care 2003;26:3153–9.
  28. Elliott P, Stamler R. Manual of operations for ‘INTERSALT’, an international cooperative study on the relation of sodium and potassium to blood pressure. Control Clin Trials 1988;9:1S–117S.
  29. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157–63.
  30. Steering Committee of the Western Pacific Region of the World Health Organization, the International Association for the Study of Obesity, and the International Obesity Task Force. The Asia-Pacific perspective: Redefining obesity and its treatment. Melbourne, Australia:Health Communications Australia; 2000.
  31. Han TS, van Leer EM, Seidell JC, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: Prevalence study in a random sample. BMJ 1995;311:1401–5.
  32. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486–97.
  33. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998;15:539–53.
  34. Lee J, Heng D, Chia KS, Chew SK, Tan BY, Hughes K. Risk factors and incident coronary heart disease in Chinese, Malay and Asian Indian males: The Singapore Cardiovascular Cohort Study. Int J Epidemiol 2001;30:983–8.
  35. Enas EA, Garg A, Davidson MA, Nair VM, Huet BA, Yusuf S. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J 1996;48:343–53.
  36. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, et al. Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: The study of health assessment and risk in ethnic groups (SHARE). Indian Heart J 2000;52:S35–S43.
  37. Bhatnagar D, Anand IS, Durrington PN, Patel DJ, Wander GS, Mackness MI, et al. Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet 1995;345:405–9.
  38. Tao S, Wu X, Duan X, Fang W, Hao J, Fan D, et al. Hypertension prevalence and status of awareness, treatment and control in China. Chin Med J (Engl) 1995;108:483–9.
  39. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 2002;40:920–7.
  40. Hypertension Study Group. Prevalence, awareness, treatment and control of hypertension among the elderly in Bangladesh and India: A multicentre study. Bull World Health Organ 2001;79:490–500.
  41. McKeigue PM, Miller GJ, Marmot MG. Coronary heart disease in south Asians overseas: A review. J Clin Epidemiol 1989;42:597–609.
  42. Hughes K, Yeo PP, Lun KC, Thai AC, Sothy SP, Wang KW, et al. Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. II. Differences in risk factor levels. J Epidemiol Community Health 1990;44:29–35.
  43. Reddy KS, Prabhakaran D, Shah P, Shah B. Differences in body mass index and waist:hip ratios in North Indian rural and urban populations. Obes Rev 2002;3:197–202.
  44. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:
    393–403.
  45. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343–50.
  46. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2003;163:427–36.

 

Cardiothoracic Sciences Centre, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
D. PRABHAKARAN, LAKSHMY RAMAKRISHNAN,
K. SRINATH REDDY Department of Cardiology
Department of Internal Medicine, Mayo Clinic, Rochester, USA
PANKAJ SHAH Division of Endocrinology
Initiative for Cardiovascular Health Research in Developing Countries, New Delhi, India
VIVEK CHATURVEDI
Initiative for Cardiovascular Health Research in Developing Countries, New Delhi, India and Division of Hospital Medicine, Hackley Hospital, Muskegon, Michigan, USA
AJAY MANHAPRA
Correspondence to K. SRINATH REDDY; ksreddy@ichealth.org

 

 

 

 

 

 

Search
NMJI Web
 
Email Email this article
Download Add to Favourites
Print Print this Article
write Write to us
write Top
 
Contact Us | Site Map | Feedback | Disclaimer